Statins (Cardiovascular Agents)

DRUG5 trials

Sponsors

Tarumanagara University, Beni-Suef University, Karolinska Institutet, University of Edinburgh, Jaime Daniel Mondragon

Conditions

Acute Coronary SyndromeAcute Pulmonary EdemaArrhythmias, CardiacCOVID-19Dementia, VascularHeart FailureMetabolic SyndromeMild Cognitive Impairment

Phase 2

Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia

CompletedNCT04301336

Beni-Suef UniversitySickle Cell Anemia in Children, Sickle Cell Disease, Vaso-occlusive Crisis

Start: 2019-11-01End: 2020-12-10Updated: 2021-01-27

Dapagliflozin Effect in Cognitive Impairment in Stroke Trial

Jaime Daniel MondragonDementia, Vascular, Metabolic Syndrome, Mild Cognitive Impairment +1

Start: 2020-08-01End: 2025-07-01Target: 270Updated: 2022-10-04

Unknown Phase

Prior Statin Use and Risk of CHF, ALO and Malignant Arrhythmia in Indonesian Post-Acute Coronary Syndrome Patients

CompletedNCT03596931

Tarumanagara UniversityAcute Coronary Syndrome, Acute Pulmonary Edema, Arrhythmias, Cardiac +1

Start: 2017-08-01End: 2018-08-31Updated: 2018-09-12

Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study

Karolinska InstitutetCOVID-19

Start: 2020-03-01End: 2023-12-31Updated: 2022-07-29

Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction

CompletedNCT05419583

University of EdinburghMyocardial Infarction Type 2

Start: 2022-11-14End: 2024-06-30Updated: 2024-09-19

Related Papers

Association between cardiometabolic disease and severe COVID-19: a nationwide case–control study of patients requiring invasive mechanical ventilation

BMJ Open2021-02-0138 citations